Select Equity Group, L.P. Bio Rad Laboratories, Inc. Transaction History
Select Equity Group, L.P.
- $24.9 Billion
- Q3 2024
A detailed history of Select Equity Group, L.P. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Select Equity Group, L.P. holds 708,452 shares of BIO stock, worth $234 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
708,452
Previous 649,522
9.07%
Holding current value
$234 Million
Previous $177 Million
33.62%
% of portfolio
0.95%
Previous 0.73%
Shares
9 transactions
Others Institutions Holding BIO
# of Institutions
456Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$631 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$513 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$431 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$359 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$236 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.14B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...